| Peer-Reviewed

The Clinical and Dynamic Characteristics of Acute Psychosis Following the Use Synthetic Cannabinoids

Received: 16 August 2018     Accepted: 7 September 2018     Published: 23 October 2018
Views:       Downloads:
Abstract

The article presents the results of research into the clinical and dynamic characteristics of psychosis following the use of synthetic cannabinoids (SC). The aim of the study is a clinical-dynamic analysis of 348 psychotic conditions following the use of synthetic cannabinoids involved 173 patients. The results of the study are: we describe the stages of psychosis development and psychosis delirious, delirious-oneiroid and amentia-like clinical variants; we demonstrated that the pathokinetic patterns of psychosis following SC use are determined by a complex of clinical, biological and socio-psychological factors; we found that the severity of clinical variants of the psychosis and consciousness disorders positively correlated with psychopathological conditions accompanied by more and more severe disorders of psychic activity (affective disorders – illusions and pareidolias – hallucinations – delusions – psychic automatism – ‘motor disorders) with simultaneous gradual depletion of psychosis psychopathologic picture resulting from the narrowing spectrum of psychopathological symptoms.

Published in American Journal of Psychiatry and Neuroscience (Volume 6, Issue 4)
DOI 10.11648/j.ajpn.20180604.11
Page(s) 95-98
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2018. Published by Science Publishing Group

Keywords

New Psychoactive Substances, Synthetic Cannabinoids, Spice, Psychosis

References
[1] Savchuk S. A. Obnaruzheniesinteticheskikhkannabimimetikov, narkoticheskikh, psikhoaktivnykhveshchestv i ikhmetabolitov v moche, volosakh i nogtyakhmetodamizhidkostnoikhromatografii s mass-spektrometricheskimdetektirovaniem. Informatsionnoepis'mo. «Narkologiya» 8/2014, str. 42-52 (In Russ.).
[2] Vsemirnyidoklad o narkotikakh, 2016 Available at: http://www.unodc.org/doc/wdr2016/WDR_2016_ExSum_russian.pdf AccessedMay10, 2017.
[3] National Institute on Drug Abuse. DrugFacts: K2/Spice («SyntheticMarijuana»). Available at: https://www.drugabuse.gov/drugs-abuse/synthetic-cannabinoids-k2spice AccessedMay10, 2017.
[4] European Monitoring Centre for Drugs and Drug Addiction. Synthetic cannabinoids and «Spice» profile. Available at: http://www.emcdda.europa.eu/publications/drug-profiles/synthetic-cannabinoids AccessedMay10, 2017.
[5] Bokhan N. A., Selivanov G. Yu. Klinicheskayatipologiyapsikhopatologicheskikhrasstroistv u potrebiteleisinteticheskikhkannabinoidov (spaisov) // Sibirskiivestnikpsikhiatriiinarkologii. -2015.-№ 4 (89). - s. 18-23. (In Russ.).
[6] Bondar' I. V, Nadezhdin A. V., Vyazovichenko Yu. E., Simonov D. V., Vishnyakov D. A. Ob aktual'nosti problemy kuritel'nykh smesei (spaisov) na sovremennom etape // sbornik materialov Vserossiiskoi nauchno-prakticheskoi konferentsii «Protivodeistvie nezakonnomu oborotu narkoticheskikh sredstv, psikhotropnykh veshchestv, ikh analogov i prekursorov v sovremennoi rossii: ugolovno-pravovoi i kriminologicheskii aspekty» / pod obshch. red. I. I. Batyrshina. – M.: FKU NITs FSKN Rossii, 2015. –s. 27-32. (In Russ.).
[7] Gordeev A. Yu. K voprosu o protivodeistvii nezakonnomu oborotu novykh vidov psikhoaktivnykh veshchestv // sbornik materialov Vserossiiskoi nauchno-prakticheskoi konferentsii «Protivodeistvie nezakonnomu oborotu narkoticheskikh sredstv, psikhotropnykh veshchestv, ikh analogov i prekursorov v sovremennoi rossii: ugolovno-pravovoi i kriminologicheskii aspekty»/ pod obshch. red. I. I. Batyrshina. – M.: FKU NITs FSKN Rossii, 2015. –s. 63-66.
[8] Vearrier, D. and Osterhoudt, K. (2010). A Teenager With Agitation. Pediatric Emergency Care, 26 (6), pp. 462-465. doi: 10.1097/PEC.0b013e3181e4f416.
[9] Rodgman, C., Kinzie, E. and Leimbach, E. (2011). Bad Mojo: use of the new marijuana substitute leads to more and more ED visits for acute psychosis. The American Journal of Emergency Medicine, 29 (2), p. 232. doi: 10.1016/j.ajem.2010.07.020.
[10] Hurst, D., Loeffler, G. and McLay, R. (2011). Psychosis Associated With Synthetic Cannabinoid Agonists: A Case Series. American Journal of Psychiatry, 168 (10), pp. 1119-1119. doi: 10.1176/appi.ajp.2011.11010176.
[11] Benford, D. and Caplan, J. (2011). Psychiatric Sequelae of Spice, K2, and Synthetic Cannabinoid Receptor Agonists. Psychosomatics, 52 (3), p. 295. doi:10.1016/j.psym.2011.01.004.
[12] Van Der Veer, N. and Friday, J. (2011). Persistent psychosis following the use of Spice. SchizophreniaResearch, 130 (1-3), pp. 285-286. doi:10.1016/j.schres.2011.04.022.
[13] Bebarta, V., Ramirez, S. and Varney, S. (2012). Spice: A New «Legal» Herbal Mixture Abused by Young Active Duty Military Personnel. Substance Abuse, 33 (2), pp. 191-194. doi: 10.1080/08897077.2011.637610.
[14] Hermanns-Clausen, M., Kneisel, S., Hutter, M., Szabo, B. and Auwärter, V. (2013). Acute intoxication by synthetic cannabinoids - Four case reports. Drug Testing and Analysis, 5 (9-10), pp. 790-794. doi: 10.1002/dta.1483.
[15] Hermanns-Clausen, M., Kneisel, S., Szabo, B. and Auwärter, V. (2012). Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction, 108 (3), pp. 534-544. doi: 10.1111/j.1360-0443.2012.04078.x.
[16] Peglow, S., Buchner, J. and Briscoe, G. (2012). Synthetic Cannabinoid Induced Psychosis in a Previously Nonpsychotic Patient. The American Journal on Addictions, 21 (3), pp. 287-288. doi: 10.1111/j.1521-391.2012.00222.x.
[17] Schwartz, M., Trecki, J., Edison, L., Steck, A., Arnold, J. and Gerona, R. (2015). A Common Source Outbreak of Severe Delirium Associated with Exposure to the Novel Synthetic Cannabinoid ADB-PINACA. The Journal of Emergency Medicine, 48 (5), pp. 573-580. doi: 10.1016/j.jemermed.2014.12.038.
[18] Fattore, L. (2016). Synthetic Cannabinoids—Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis. Biological Psychiatry, 79 (7), pp. 539-548. http://dx.doi.org/10.1016/j.biopsych.2016.02.001.
Cite This Article
  • APA Style

    Kekelidze Zurab Ilich, Klimenko Tatiana Valentinovna, Kozlov Alexandr Alexandrovich, Shakhova Svetlana Michailovna. (2018). The Clinical and Dynamic Characteristics of Acute Psychosis Following the Use Synthetic Cannabinoids. American Journal of Psychiatry and Neuroscience, 6(4), 95-98. https://doi.org/10.11648/j.ajpn.20180604.11

    Copy | Download

    ACS Style

    Kekelidze Zurab Ilich; Klimenko Tatiana Valentinovna; Kozlov Alexandr Alexandrovich; Shakhova Svetlana Michailovna. The Clinical and Dynamic Characteristics of Acute Psychosis Following the Use Synthetic Cannabinoids. Am. J. Psychiatry Neurosci. 2018, 6(4), 95-98. doi: 10.11648/j.ajpn.20180604.11

    Copy | Download

    AMA Style

    Kekelidze Zurab Ilich, Klimenko Tatiana Valentinovna, Kozlov Alexandr Alexandrovich, Shakhova Svetlana Michailovna. The Clinical and Dynamic Characteristics of Acute Psychosis Following the Use Synthetic Cannabinoids. Am J Psychiatry Neurosci. 2018;6(4):95-98. doi: 10.11648/j.ajpn.20180604.11

    Copy | Download

  • @article{10.11648/j.ajpn.20180604.11,
      author = {Kekelidze Zurab Ilich and Klimenko Tatiana Valentinovna and Kozlov Alexandr Alexandrovich and Shakhova Svetlana Michailovna},
      title = {The Clinical and Dynamic Characteristics of Acute Psychosis Following the Use Synthetic Cannabinoids},
      journal = {American Journal of Psychiatry and Neuroscience},
      volume = {6},
      number = {4},
      pages = {95-98},
      doi = {10.11648/j.ajpn.20180604.11},
      url = {https://doi.org/10.11648/j.ajpn.20180604.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajpn.20180604.11},
      abstract = {The article presents the results of research into the clinical and dynamic characteristics of psychosis following the use of synthetic cannabinoids (SC). The aim of the study is a clinical-dynamic analysis of 348 psychotic conditions following the use of synthetic cannabinoids involved 173 patients. The results of the study are: we describe the stages of psychosis development and psychosis delirious, delirious-oneiroid and amentia-like clinical variants; we demonstrated that the pathokinetic patterns of psychosis following SC use are determined by a complex of clinical, biological and socio-psychological factors; we found that the severity of clinical variants of the psychosis and consciousness disorders positively correlated with psychopathological conditions accompanied by more and more severe disorders of psychic activity (affective disorders – illusions and pareidolias – hallucinations – delusions – psychic automatism – ‘motor disorders) with simultaneous gradual depletion of psychosis psychopathologic picture resulting from the narrowing spectrum of psychopathological symptoms.},
     year = {2018}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - The Clinical and Dynamic Characteristics of Acute Psychosis Following the Use Synthetic Cannabinoids
    AU  - Kekelidze Zurab Ilich
    AU  - Klimenko Tatiana Valentinovna
    AU  - Kozlov Alexandr Alexandrovich
    AU  - Shakhova Svetlana Michailovna
    Y1  - 2018/10/23
    PY  - 2018
    N1  - https://doi.org/10.11648/j.ajpn.20180604.11
    DO  - 10.11648/j.ajpn.20180604.11
    T2  - American Journal of Psychiatry and Neuroscience
    JF  - American Journal of Psychiatry and Neuroscience
    JO  - American Journal of Psychiatry and Neuroscience
    SP  - 95
    EP  - 98
    PB  - Science Publishing Group
    SN  - 2330-426X
    UR  - https://doi.org/10.11648/j.ajpn.20180604.11
    AB  - The article presents the results of research into the clinical and dynamic characteristics of psychosis following the use of synthetic cannabinoids (SC). The aim of the study is a clinical-dynamic analysis of 348 psychotic conditions following the use of synthetic cannabinoids involved 173 patients. The results of the study are: we describe the stages of psychosis development and psychosis delirious, delirious-oneiroid and amentia-like clinical variants; we demonstrated that the pathokinetic patterns of psychosis following SC use are determined by a complex of clinical, biological and socio-psychological factors; we found that the severity of clinical variants of the psychosis and consciousness disorders positively correlated with psychopathological conditions accompanied by more and more severe disorders of psychic activity (affective disorders – illusions and pareidolias – hallucinations – delusions – psychic automatism – ‘motor disorders) with simultaneous gradual depletion of psychosis psychopathologic picture resulting from the narrowing spectrum of psychopathological symptoms.
    VL  - 6
    IS  - 4
    ER  - 

    Copy | Download

Author Information
  • V. Serbsky Federal Medical Research Center of Psychiatry and Addiction, Ministry of Health, Moscow, Russian Federation

  • V. Serbsky Federal Medical Research Center of Psychiatry and Addiction, Ministry of Health, Moscow, Russian Federation

  • V. Serbsky Federal Medical Research Center of Psychiatry and Addiction, Ministry of Health, Moscow, Russian Federation

  • V. Serbsky Federal Medical Research Center of Psychiatry and Addiction, Ministry of Health, Moscow, Russian Federation

  • Sections